In vivo disruption of latent HSV by designer endonuclease therapy-Reference-Cited by-同舟云学术

In vivo disruption of latent HSV by designer endonuclease therapy

Published:2016-09-08 Issue:14 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Aubert Martine,Madden Emily A.,Loprieno Michelle,Feelixge Harshana S. DeSilva,Stensland Laurence,Huang Meei-Li,Greninger Alexander L.,Roychoudhury Pavitra,Niyonzima Nixon,Nguyen Thuy,Magaret Amalia,Galleto Roman,Stone Daniel,Jerome Keith R.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference60 articles.

1. Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections

2. Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling

3. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

4. Effect of Valacyclovir on Viral Shedding in Immunocompetent Patients With Recurrent Herpes Simplex Virus 2 Genital Herpes: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo;Nature Communications;2024-05-13

2. Summary of the Centers for Disease Control and Prevention/National Institute of Allergy and Infectious Diseases Joint Workshop on Genital Herpes: 3–4 November 2022;Open Forum Infectious Diseases;2024-04-24

3. Modulation of Equid Herpesvirus-1 Replication Dynamics In Vitro Using CRISPR/Cas9-Assisted Genome Editing;Viruses;2024-03-06

4. Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection in vitro and in vivo;Acta Pharmaceutica Sinica B;2023-10

5. Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies;Microbiology Spectrum;2023-06-15